Evidence map›Paper›PMID 30008330›Full record

ArticleCurrent biology : CB2018

Marked Diversity of Unique Cortical Enhancers Enables Neuron-Specific Tools by Enhancer-Driven Gene Expression.

Stefan Blankvoort, Menno P Witter, James Noonan, Justin Cotney, Cliff Kentros

Abstract read
In one paragraph

Article in Current biology : CB, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. AnFrontiers in genetics · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Stefan BlankvoortKavli Institute for Systems Neuroscience and Centre for Neural Computation, NTNU, Trondheim, Norway.
Menno P WitterKavli Institute for Systems Neuroscience and Centre for Neural Computation, NTNU, Trondheim, Norway.
James NoonanDepartment of Genetics, Yale School of Medicine, New Haven, CT, USA; Kavli Institute for Neuroscience, Yale University, New Haven, CT, USA.
Justin CotneyDepartment of Genetics, Yale School of Medicine, New Haven, CT, USA; Department of Genetics and Genome Sciences, University of Connecticut Health Centre, Farmington, CT, USA. Electronic address: cotney@uchc.edu.
Cliff KentrosKavli Institute for Systems Neuroscience and Centre for Neural Computation, NTNU, Trondheim, Norway; Institute of Neuroscience, University of Oregon, Eugene, OR, USA. Electronic address: clifford.kentros@ntnu.no.

Funding

Identifying enhancers with human-specific developmental functionsR01GM094780 · NIGMS · YALE UNIVERSITY · PI NOONAN, JAMES P · 2010 to 2018
$5.8M
Unraveling mechanisms of genome regulation to understand and improvehuman healthR35GM119465 · NIGMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI COTNEY, JUSTIN LEE · 2016 to 2025
$3.9M
NIGMS NIH HHS R01 GM094780NIGMS NIH HHS R35 GM119465
6 · The paper itself

Abstract

Understanding neural circuit function requires individually addressing their component parts: specific neuronal cell types. However, not only do the precise genetic mechanisms specifying neuronal cell types remain obscure, access to these neuronal cell types by transgenic techniques also remains elusive. Whereas most genes are expressed in the brain, the vast majority are expressed in many different kinds of neurons, suggesting that promoters alone are not sufficiently specific to distinguish cell types. However, there are orders of magnitude more distal genetic cis-regulatory elements controlling transcription (i.e., enhancers), so we screened for enhancer activity in microdissected samples of mouse cortical subregions. This identified thousands of novel putative enhancers, many unique to particular cortical subregions. Pronuclear injection of expression constructs containing such region-specific enhancers resulted in transgenic lines driving expression in distinct sets of cells specifically in the targeted cortical subregions, even though the parent gene's promoter was relatively non-specific. These data showcase the promise of utilizing the genetic mechanisms underlying the specification of diverse neuronal cell types for the development of genetic tools potentially capable of targeting any neuronal circuit of interest, an approach we call enhancer-driven gene expression (EDGE).

Indexed as

Enhancer Elements, GeneticGene ExpressionPromoter Regions, GeneticAnimalsAnimals, Genetically ModifiedFemaleMaleMiceMice, Inbred C57BLNeuronsenhancersentorhinal cortexepigeneticsneural circuitstranscriptional controltransgene expressiontransgenic animalstransgenic methodstransgenics

Identifiers

PMID30008330
PMCPMC7301410

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.